Evidence map›Paper›PMID 42758420›Full record

ArticleEuropean radiology experimental2026

Automated three-dimensional radiomic body composition analysis enhances survival prediction in resectable non‑small cell lung cancer.

Yilong Huang, Chuanpu Li, Fan Yang, Xin Chen, Xiaobo Chen, Yanqi Huang, Zhenguang Zhang, Lei Yang, Yuanming Jiang, Hanxue Cun and 4 more

Abstract readMulticenter Study
In one paragraph

Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yilong Huang *Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Chuanpu Li *School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
Fan Yang *The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Xin ChenDepartment of Radiology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Xiaobo ChenDepartment of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yanqi HuangDepartment of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhenguang ZhangDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Lei YangDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yuanming JiangDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Hanxue CunDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhanglin MouDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Wei YangSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China. weiyanggm@gmail.com.
Zaiyi LiuDepartment of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. liuzaiyi@gdph.org.cn.
Bo HeDepartment of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China. kmmu_hb@163.com.ORCID http://orcid.org/0009-0008-7890-7717

Funding

535 Talent Project of First Affiliated Hospital of Kunming Medical University 2025535Q04First-Class Discipline Team of Kunming Medical University 2024XKTDTS03National Natural Science Foundation of China 82460348, 82302131, 82260338, 82371954Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0531100, 2024ZD0531101Yunnan Fundamental Research Projects 202301AS070001, 202501AY070001-075Yunnan High-level Medical Talent Projects D2024060, D202406075Yunnan Provincial Education Department Scientific Research Fund Project 2024J0207
6 · The paper itself

Abstract

objectiveTo develop and validate a machine learning radiomics model integrating automated three-dimensional body composition and tumor imaging features for predicting overall survival in resectable non-small cell lung cancer (NSCLC). MATERIALS AND

methodsThis multicenter retrospective study included patients with resectable NSCLC treated between January 2013 and December 2017, who were assigned to training, internal, and external validation cohorts. A fully automated deep learning algorithm was developed for body composition segmentation. Radiomic features from tumor and body composition were extracted and integrated using extreme gradient boosting. Model performance was assessed using the concordance index (C-index) and time-dependent area under the curve (AUC), with interpretability evaluated by SHapley Additive exPlanations (SHAP). Kaplan-Meier analysis was performed for survival stratification.

resultsAmong 1,038 patients (mean age, 61.8 ± 10.7 years; 58.66% male), 293 (28.2%) died over a median follow-up of 3.31 years. In the training cohort, both tumor score and body composition score were independently associated with overall survival (hazard ratio 2.72 and 2.03, respectively; all p < 0.001). Incorporating body composition radiomics significantly improved discrimination compared with tumor-only models across cohorts (all p < 0.05). The comprehensive model, integrating clinicopathological factors, tumor score, and body composition score, demonstrated strong predictive capability for 1, 2, 3, and 5-year survival (AUCs > 0.80). SHAP analysis identified tumor score and body composition score as dominant predictors, stratifying patients into four phenotypes with distinct prognoses (all log-rank p < 0.05).

conclusionIntegrating automated three-dimensional body composition with tumor radiomics enhances survival prediction and provides incremental value for postoperative risk stratification in resectable NSCLC. KEY POINTS: Question Standard staging for resectable non-small cell lung cancer lacks objective three-dimensional quantification of host body composition, thereby limiting individualized prognostic assessment. Findings Machine learning models integrating automated three-dimensional body composition and tumor radiomics significantly outperform conventional tumor imaging in overall survival prediction. Relevance statement Automated three-dimensional body composition radiomics integrated with tumor imaging improves survival prediction in resectable non-small cell lung cancer, enabling more precise postoperative risk stratification and supporting individualized follow-up and supportive care strategies.

Indexed as

Body CompositionCarcinoma, Non-Small-Cell LungImaging, Three-DimensionalLung NeoplasmsRadiomicsAgedFemaleHumansMachine LearningMaleMiddle AgedPrognosisRetrospective StudiesTomography, X-Ray ComputedArtificial intelligenceBody compositionNon-small cell lung cancerRadiomicsSurvival prediction

Identifiers

PMID42758420
PMCPMC13588999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.